Literature DB >> 22674758

The association between overactive bladder and fibromyalgia syndrome: a community survey.

Jae Hoon Chung1, Shin Ah Kim, Bo Youl Choi, Hye-Soon Lee, Seung Wook Lee, Yong Tae Kim, Tchun Yong Lee, Hong Sang Moon.   

Abstract

AIMS: Fibromyalgia syndrome (FMS) is the most common disease causing chronic generalized pain, and FMS patients often complain of urinary symptoms such as frequency or urgency. This study focuses on the association of overactive bladder (OAB) and FMS in adults aged 40 and over.
METHODS: A survey of adults aged 40s and over was conducted in the Guri and Yangpyeong areas of South Korea. The response rate was 74.2% (940/1,266). After excluding subjects with incomplete questionnaires (n = 20), 920 were included in the final analysis. The association of FMS and OAB was analyzed by univariate and multivariate logistic regression analysis.
RESULTS: Individuals with FMS had a significantly increased symptoms of OAB after adjustment for gender, age group, and area of residence (odds ratio (OR) 3.39, 95% confidence interval (CI) 1.82-6.31). The association between FMS and severity of OAB was statistical significant (P for trend <0.0001).
CONCLUSIONS: OAB is associated with FMS. Moreover FMS increases with severity of OAB.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22674758     DOI: 10.1002/nau.22277

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  10 in total

Review 1.  Does central sensitization help explain idiopathic overactive bladder?

Authors:  W Stuart Reynolds; Roger Dmochowski; Alan Wein; Stephen Bruehl
Journal:  Nat Rev Urol       Date:  2016-06-01       Impact factor: 14.432

2.  Lower urinary tract symptoms and perineal function in women with and without fibromyalgia: a cross-sectional study.

Authors:  Hellen Cristina Souza de Carvalho Fusco; Marco Antônio Gonçalves Pontes Filho; Jorge Milhem Haddad; Míriam Raquel Diniz Zanetti; Amélia Pasqual Marques; Elizabeth Alves Gonçalves Ferreira
Journal:  Clin Rheumatol       Date:  2019-05-31       Impact factor: 2.980

3.  Somatic syndromes and chronic pain in women with overactive bladder.

Authors:  W Stuart Reynolds; Stephen Mock; Xuechao Zhang; Melissa Kaufman; Alan Wein; Stephen Bruehl; Roger Dmochowski
Journal:  Neurourol Urodyn       Date:  2016-07-01       Impact factor: 2.696

4.  Systemic Nonurological Symptoms in Patients with Overactive Bladder.

Authors:  H Henry Lai; Joel Vetter; Sanjay Jain; Gerald L Andriole
Journal:  J Urol       Date:  2016-03-17       Impact factor: 7.450

5.  Experimental Pain and Auditory Sensitivity in Overactive Bladder Syndrome: A Symptoms of the Lower Urinary Tract Dysfunction Research Network (LURN) Study.

Authors:  Steven E Harte; Jon Wiseman; Ying Wang; Abigail R Smith; Claire C Yang; Margaret Helmuth; Karl Kreder; Grant H Kruger; Brenda W Gillespie; Cindy Amundsen; Ziya Kirkali; H Henry Lai
Journal:  J Urol       Date:  2022-08-25       Impact factor: 7.600

Review 6.  Overactive bladder.

Authors:  Karen M Wallace; Marcus J Drake
Journal:  F1000Res       Date:  2015-12-07

7.  Pregabalin Prescription for Neuropathic Pain and Fibromyalgia: A Descriptive Study Using Administrative Database in Japan.

Authors:  Mikito Hirakata; Satomi Yoshida; Sachiko Tanaka-Mizuno; Aki Kuwauchi; Koji Kawakami
Journal:  Pain Res Manag       Date:  2018-06-05       Impact factor: 3.037

8.  Clinical Manifestations of Overactive Bladder With Migraine as a Comorbidity: A Prospective Cross-Sectional Study.

Authors:  Aykut Baser; Sinan Eliaçık; Mehmet Murat Baykam; Funda Uysal Tan
Journal:  Int Neurourol J       Date:  2020-12-09       Impact factor: 2.835

9.  Clinical Manifestations Associated with Overweight/Obesity in Puerto Ricans with Fibromyalgia Syndrome.

Authors:  Ruth M Fred-Jiménez; Mariangelí Arroyo-Ávila; Ángel M Mayor; Grissel Ríos; Luis M Vilá
Journal:  J Obes       Date:  2016-01-18

10.  Ambroxol for the treatment of fibromyalgia: science or fiction?

Authors:  Kai-Uwe Kern; Myriam Schwickert
Journal:  J Pain Res       Date:  2017-08-16       Impact factor: 3.133

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.